NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Yale University
Conditions: HIV, CVD, Metabolic Disease
Interventions: LEARN 2 Platform
Countries: United States
The goal of this waitlist control clinical trial is to learn if the tailored LEARN 2 platform can prevent HIV-related comorbidities with shared risk factors in men ages 18 and older living with HIV. The main question\[s\] are: 1. Can the virtual environment improve quality of life among these participants? 2. Does the LEARN 2 platform effectively serve as prevention education for HIV comorbidity shared risk factors? Researchers will compare participants receiving the LEARN2 virtual environment intervention to those in a waitlist control group to see if the intervention leads to improvements in quality of life and reductions in risk factors. Participants will be asked to: 1. Engage with the virtual environment weekly. 2. Participate in virtual live health educator sessions. 3. Complete daily assessments of personal health behaviors through Ecological Momentary Assessment.
Sex: MALE
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria: Self-identify as: * living with HIV * English speaking * Access to a device compatible with LEARN 2 Exclusion Criteria: \- medical history of serious complications such as heart attack, stroke, cognitive impairment, or cancer.
- Orange, Connecticut, United States